Yes, steroids can affect your liver, but the type of steroid and how you take it make a big difference in the kind and severity of damage. Oral anabolic steroids are the most liver-toxic, capable of causing jaundice, blood-filled cysts, and in rare cases, liver tumors. Corticosteroids like prednisone affect the liver differently, primarily by promoting fat buildup. Most mild liver changes from steroids reverse once you stop taking them, but serious complications can develop with prolonged or heavy use.
Why Oral Steroids Are Hardest on the Liver
Most oral anabolic steroids are chemically modified so they survive the trip through your digestive system without being broken down too quickly. This modification, known as 17-alpha-alkylation, is what makes them effective as pills, but it also forces the liver to work much harder to process the drug. Every dose passes directly through the liver before reaching the rest of your body, and the chemical structure resists the liver’s normal breakdown process. That repeated stress on liver cells is the primary driver of damage.
Injectable testosterone and other non-alkylated steroids bypass this first-pass metabolism through the liver. They enter the bloodstream through muscle tissue instead, which is why injectable forms are generally much easier on the liver. The most serious liver complications, including cholestasis and tumors, are overwhelmingly linked to oral compounds.
What Shows Up on Blood Tests
Steroid-related liver stress typically shows up as elevated liver enzymes on a standard blood panel. ALT (alanine aminotransferase) is the most closely watched marker. In a study of 58 bodybuilders, current users had a mean ALT of 57 U/L compared to 19 U/L in people who had never used steroids. During an active cycle, levels rose from 29 to 67 U/L. Normal ALT is generally below 56 U/L, so many users hover right at or slightly above the upper limit.
These elevations are usually modest, typically two to three times the normal range, and often cause no symptoms at all. In one study of 30 patients on an oral steroid called methandienone, 27% developed elevated liver enzymes, but none had symptoms, and the numbers dropped quickly. In a study of 54 patients on another oral compound, about a third showed minor enzyme bumps that reversed on their own.
One complication with interpreting these results: intense weight training itself can raise certain liver enzymes, particularly AST. So a mildly elevated AST in someone who lifts heavy doesn’t automatically mean liver damage. ALT is more specific to the liver and a better indicator of actual hepatic stress in steroid users.
Cholestasis: The Most Common Serious Problem
The signature liver injury from oral anabolic steroids is a condition called cholestasis, where bile flow from the liver slows or stops. Bile backs up into the bloodstream, causing yellowing of the skin and eyes (jaundice), dark urine, itching, fatigue, and nausea. What makes steroid-induced cholestasis distinctive is that bilirubin levels can climb extremely high while liver enzymes stay relatively low. In a review of 44 cases of anabolic steroid jaundice, the average bilirubin was 9.8 mg/dL and climbed to 25.8 mg/dL (normal is under 1.2), while ALT was only 169 U/L.
Some cases are far more dramatic. Two users of stanozolol developed bilirubin levels of 48 and 49 mg/dL, deep jaundice by any measure, yet their ALT levels were just 33 and 66 U/L. This pattern of severe jaundice with minimal inflammation is so characteristic of anabolic steroid use that it can essentially confirm the diagnosis on its own. The liver itself isn’t heavily inflamed; bile is simply not flowing properly.
Peliosis Hepatis and Liver Tumors
A rarer but more dangerous condition is peliosis hepatis, where blood-filled cysts develop throughout the liver tissue. Unlike cholestasis, which is mainly linked to oral steroids, peliosis has been reported with both oral and injectable testosterone. Most cases cause no symptoms and are discovered incidentally on imaging. The danger comes if a cyst ruptures, which can cause sharp abdominal pain and internal bleeding.
Long-term anabolic steroid use is also linked to the development of benign liver tumors called hepatocellular adenomas. These growths are well-documented in steroid users and carry a small but real risk of transforming into liver cancer. The estimated rate of an adenoma becoming malignant is around 4%. Actual liver cancer from steroid use remains rare, but cases have been reported in otherwise young, healthy bodybuilders with no other risk factors. Two such cases appeared at a single surgical center in South Wales within six months, both in young men using anabolic steroids.
Corticosteroids Affect the Liver Differently
If you’re taking corticosteroids like prednisone or methylprednisolone for an autoimmune condition, allergy, or inflammatory disease, the liver risk profile looks quite different from anabolic steroids. Corticosteroids don’t typically cause cholestasis or tumors. Instead, prolonged use promotes fat accumulation in the liver, a condition called fatty liver disease.
This happens through several overlapping mechanisms. Corticosteroids increase appetite, stimulate the liver to produce new fat from sugar, boost the release of fatty acids from fat tissue, and simultaneously block the liver’s ability to burn fat for energy. The net result is a steady buildup of triglycerides in liver cells. In animal studies, fatty liver develops within just a few days of high-dose corticosteroid exposure. In humans, the timeline depends on dose and duration, but months of daily use significantly raises the risk.
High-dose intravenous corticosteroids, commonly used for conditions like multiple sclerosis flares, can also cause short-term liver enzyme spikes. Monitoring liver function before treatment and about two weeks afterward is recommended for patients receiving these pulses.
How the Liver Recovers After Stopping
The good news is that most steroid-related liver changes are reversible. Mild enzyme elevations from anabolic steroids typically resolve within weeks to months of stopping. In one documented case, a bodybuilder’s ALT was 237 U/L six weeks after stopping anabolic steroids. By five months, it had dropped to 33 U/L, well within the normal range. The trajectory wasn’t perfectly smooth (it fluctuated along the way), but the overall trend was clear recovery.
Cholestasis also resolves after stopping the offending steroid, though jaundice can take weeks to clear because bilirubin levels come down gradually. Peliosis hepatis may improve once steroid use ends, but cysts that have already formed don’t always disappear completely. Liver adenomas may shrink after cessation, but larger ones or those with suspicious features sometimes require surgical removal to prevent complications.
The liver’s ability to regenerate is remarkable, but it has limits. Repeated cycles of heavy oral steroid use over years push the liver harder each time, and cumulative damage from ongoing use raises the risk of complications that don’t fully reverse. The earlier you catch a problem through bloodwork, the better the odds of complete recovery.
Signs of Liver Trouble to Watch For
Many steroid users with abnormal liver values feel completely fine, which is why blood tests are the most reliable early warning. Still, there are symptoms worth knowing:
- Jaundice: yellowing of the skin or whites of the eyes
- Dark urine: a tea or cola color, even when well-hydrated
- Persistent itching: caused by bile salts depositing in the skin
- Right-sided abdominal pain: particularly a dull ache under the ribs
- Unusual fatigue or nausea: especially if it doesn’t match your training load
Jaundice in a steroid user is never something to ignore. While the underlying cholestasis is usually reversible, bilirubin levels in documented cases have reached 20 to 50 mg/dL, levels that require medical evaluation and monitoring until they normalize.